Seizures of potentially dangerous weight loss drugs being sold on the black market in Scotland have soared as online dealers ...

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using a GLP-1 to help her progress. The nurse initially kickstarted her wellness ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

New weight loss drugs work by switching off your appetite but, says leading psychological therapist Jo Silver, turning off ...

With age comes wisdom. But you know what else can come with age? Weight gain. Losing weight can also be harder as you grow ...

A man who took Ozempic and then became legally blind is suing the manufacturer, arguing it should have warned patients that ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final resolution.

The decision came in response to a February lawsuit from a compounding industry group against the FDA's decision that there ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

DEAR PEOPLE’S PHARMACY: I’ve been on Ozempic for several months now. My blood sugar in the morning is around 103, down from ...